Results

Total Results: 153 records

Showing results for "central nervous".

1. Stem-Cell-Children Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
   February 01, 2012 - Neuroblastoma, germ cell tumors, and central nervous system embryonal tumors are covered in both narrative … Neuroblastoma, germ cell tumors, and central nervous system embryonal tumors are covered in both narrative … nervous system embryonal tumors Relapsed or residual Auto NM Hemoglobinopathies Variable Allo NM Bone … auto MNH Central nervous system glial tumors Consolidate high risk Auto Conventional chemotherapy … nervous system) involvement, high-risk Ewing’s sarcoma family of tumors, and high-risk relapsed Wilm

2. Management and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
   May 01, 2016 - Food and Drug Administration (FDA) approved lisdexamfetamine, a central nervous system stimulant, as … interval; BMI = body mass index; BWL = behavioral weight loss; CBT = cognitive behavioral therapy; CNS = central … nervous system; MA = meta-analysis; MD = mean difference; N = number; RCT = randomized controlled … (283 vs. 59) Lisdexamfetamine was associated with a higher number of events related to sympathetic nervous … �� 22 (15 vs. 7) Fluvoxamine was associated with a higher number of events related to sympathetic nervous

3. Effective Health Care (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0359_10-15-2010.pdf
   January 01, 2010 -  MS is a chronic, autoimmune disease of the central nervous system that can cause significant

4. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
   March 23, 2019 - ondansetron) o Antihistamines (e.g., meclizine, diphenhydramine, dimenhydrinate, promethazine) o Central … nervous system stimulants (e.g., caffeine) o Muscle relaxants (e.g., baclofen, tizanidine, metaxalone … Nervous System Stimulants”[Mesh] OR “Tryptamines”[Mesh] OR “narcotics”[Mesh] OR “Analgesics, Opioid … Nervous System Stimulants”[Mesh] OR “Tryptamines”[Mesh] OR “narcotics”[Mesh] OR “Analgesics, Opioid … nervous system stimulant' OR caffeine OR 'muscle relaxant' OR baclofen OR cyclobenzaprine OR tizanidine

5. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
   February 01, 2008 - nervous system neurons and range in severity from symptoms not readily apparent to an observer to dramatic … Lennox-Gastaut Epilepsy syndrome is associated with central nervous system delays or dysfunction from … Unfortunately, many patients have a poor prognosis due to the underlying central nervous system pathology … nervous system lesions (head trauma, infections, and brain tumors). … nervous system infection Trauma Idiopathic Adolescents/Young Adults Trauma Genetic disorders

6. Stem-Cell-Children Surveillance (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
   October 29, 2012 - benefit with single HSCT compared with conventional therapy for extraocular retinoblastoma with CNS (central … nervous system) involvement, high-risk Ewing’s sarcoma family of tumors, and high-risk relapsed Wilm … nervous system; ERT=enzyme replacement therapy 12 References 1. … nervous system) involvement, high-risk Ewing’s sarcoma family of tumors, and high-risk relapsed Wilm … nervous system This CER’s priority for updating is Low Authors: Investigators: Alexander

7. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
   December 01, 2013 - 4 receptors and insulin-sensitive glucose transporters, which regulate energy metabolism in the central … nervous system by mediating glucose uptake in cells, are colocated in brain structures that are involved … nervous system via the olfactory and trigeminal neural pathways at doses low enough to avoid significant … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … nervous system and treat neurodegenerative disease.

8. Comparative Effectiveness Review No. 241_Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
   October 01, 2021 - etiology and pathophysiology, a common denominator is the involvement of the corticospinal tracts of the central … nervous system, which results in impaired central control and/or coordination of the peripheral muscles

9. MS Protocol draft_12_12-13 clean[2] (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
   December 17, 2013 - sheath (the insulating layer around the nerves in the brain and spinal cord) and axon loss within the central … nervous system. … nervous system and the type of MS. … nervous system, may or may not go on to develop MS. … Trials (CENTRAL), PsychInfo, and Scopus.

10. VU EPC DBD Protocol_AHRQ comments_revised_clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
    January 30, 2014 - nervous system stimulants, first- generation antipsychotics, second-generation (atypical) antipsychotics … nervous system stimulants, first- generation antipsychotics, selective serotonin reuptake inhibitors … nervous system (CNS) stimulants • Olanzapine (Zyprexa®) • Levetiracetam (Keppra®) • Amphetamine- … Nervous System Stimulants"[Mesh] 2353195 #13 eng[la] AND (child[mh] OR adolescent[mh]) 1775464 … Nervous System Stimulants"[Mesh] OR "Central Nervous System Stimulants" [Pharmacological Action] OR

11. Management of suspected opioid overdose with Naloxone by Emergency Medical Services personnel (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
    November 29, 2016 - leading cause of injury death in the United States.4 Overdoses due to opioids occur as a result of their central … nervous system effects, which cause respiratory depression that can progress to cardiac arrest if untreated … Other risk factors include concomitant use of other medications and substances with central nervous … may range from 7.5:1 to 30:1.16,17 Naloxone is an opioid antagonist used to rapidly counteract the central … nervous system (CNS) and respiratory depressant effects of opioids, potentially preventing fatal overdose

12. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
    July 09, 2013 - nervous system by mediating glucose uptake in cells, are colocated in brain structures that are involved … nervous system by mediating glucose uptake in cells, are colocated in brain structures that are involved … Peripheral and Central Nervous System Drugs Advisory Committee. … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … nervous system and treat neurodegenerative disease.

13. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
    May 19, 2020 - , emergency room visits Patient-centered adverse effects of breathlessness treatments (KQ4) • Central … nervous system (cognitive changes, dizziness, drowsiness, fatigue, headache, respiratory depression … Utilization outcomes linked to dyspnea Patient-centered adverse effects of dyspnea treatments • Central … nervous system (cognitive changes, dizziness, drowsiness, fatigue, headache, respiratory depression … following databases for primary studies: PubMed, Embase®, CINAHL, ISI Web of Science, and the Cochrane Central

14. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
    March 01, 2009 - Initiators of conventional APMs also had a higher risk for death due to respiratory diseases, nervous … Other frequent causes included cancer, respiratory diseases, nervous system and mental disorders, each … Of 286 deaths due to nervous system disorders, 188 were from Alzheimer's disease and 40 were from Parkinson's … The central role of the propensity score in observational studies for causal effects. … infection 21 0.4 25 0.2 Respiratory (except pneumonia) 167 2.9 181 1.6 COPD 107 1.8 117 1.3 Nervous

15. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
    January 01, 2012 - nervous system by mediating glucose uptake in cells, are colocalized in brain structures that are … blood glucose levels. 34 Drugs administered intranasally, however, are delivered directly to the central … nervous system via the olfactory and trigeminal neural pathways, bypassing the blood-brain barrier … Peripheral and Central Nervous System Drugs Advisory Committee. … tool=pubmed 10 therapeutic agents to the central nervous system and treat neurodegenerative

16. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
    February 01, 2015 - nervous system, are co-located brain regions known to be affected by disease progression in patients … Insulin receptors and insulin-sensitive glucose transporters, which regulate energy metabolism in the central … nervous system (CNS) by mediating glucose uptake in cells, are co-located in brain structures that … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … nervous system and treat neurodegenerative disease.

17. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - nervous system by mediating glucose uptake in cells, are colocated in brain structures that are involved … nervous system via the olfactory and trigeminal neural pathways, bypassing the blood-brain barrier … Peripheral and Central Nervous System Drugs Advisory Committee. … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central … nervous system and treat neurodegenerative disease.

18. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - thoughts �� Possible respiratory depression in people with severe lung disease or sleep apnea CNS = central … nervous system a Adverse effects reported in randomized controlled trials and observational studies

19. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
    December 01, 2023 - disease, pulmonary disease, musculoskeletal disease, blood disorders, mental disorders, 4 central … nervous system disorders, rheumatic heart disease, anemia, and asthma).6 Finally, if rural Indigenous

20. Medicare-Medication-Use Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
    April 01, 2014 - Reducing costs of acute care for ambulatory care- sensitive medical conditions: the central roles of … nervous system agents Antispychotics/antimanic Nutritional products Dietary products / dietary obesity … nervous system agents Hypnotics Nutritional products Minerals and electrolytes Analgesics and anesthetics … nervous system agents Antianxiety agents Neuromuscular drugs Musculoskeletal therapy agents Neuromuscular … agentsCentral nervous system agents Antidepressants Neuromuscular drugs 15 Medication Use in Medicare